Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Phibro Animal HealthFRA:PB8 76 FCF Margin % is 1.32% as of Jun. 2026, which is 51% below its 10-year median of 2.72. GuruFocus rates FRA:PB8 with a GF Score™ of 76/100 and a GF Value™ of €27.40 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 963 Drug Manufacturers companies, Phibro Animal Health ranks worse than 56.18% on this metric.
The historical data trend for Phibro Animal Health's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PB8 vs XERS, HROW, ANIP: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phibro Animal Health FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Phibro Animal Health's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phibro Animal Health (FRA:PB8) has a FCF Margin % of 1.32% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Phibro Animal Health and its competitors. This is 51% below median its historical median of 2.72. According to the industry distribution chart, Phibro Animal Health ranks #541 out of 963 companies in the Drug Manufacturers industry, placing it in the top 56.2%.
Is Phibro Animal Health's FCF Margin % too high?
Phibro Animal Health's current FCF Margin % of 1.32% is 51% below median its 10-year median of 2.72. The Drug Manufacturers industry median FCF Margin % is 2.78. Phibro Animal Health's value of 1.32% is 52.5% below this industry median. Based on the distribution chart, Phibro Animal Health ranks #541 out of 963 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Phibro Animal Health has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Phibro Animal Health's FCF Margin % compare to XERS and HROW?
According to the Drug Manufacturers industry distribution chart, Phibro Animal Health ranks #541 out of 963 companies for FCF Margin %. This places Phibro Animal Health in the lower half of its industry. The industry median FCF Margin % is 2.78. Phibro Animal Health's value of 1.32% is 52.5% below this benchmark. While the company's 10-year median is 2.72 vs. the industry median of 2.78, Phibro Animal Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.78, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phibro Animal Health's current FCF Margin % of 1.32% is 52.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Phibro Animal Health and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phibro Animal Health's current FCF Margin % is 1.32%, which is 51% below median its own 10-year median of 2.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phibro Animal Health stock overvalued right now?
Based on GuruFocus' analysis, Phibro Animal Health (FRA:PB8) is currently considered Modestly Overvalued. The stock's GF Value™ is €27.40, compared to a current price of €32.60 — trading 19% above its estimated fair value. The current FCF Margin % is 1.32%, which is 51% below median its 10-year median of 2.72 and 52.5% below the Drug Manufacturers industry median of 2.78. Phibro Animal Health's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Phibro Animal Health (FRA:PB8), the current FCF Margin % is 1.32% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Phibro Animal Health (FRA:PB8) Overvalued in 2026?
Based on GuruFocus' analysis, Phibro Animal Health stock appears to be overvalued.
The current stock price of €32.60 is trading 19% above its estimated GF Value™ of €27.40.
GuruFocus considers Phibro Animal Health to be Modestly Overvalued.
Key valuation signals for FRA:PB8:
FCF Margin %: 1.32% (51% below median its 10-year median of 2.72)
GF Value™: €27.40 vs. price of €32.60 (19% above fair value)
Industry Position: 52.5% below the Drug Manufacturers median (#541 of 963)
No single metric tells the full story. See the FRA:PB8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
76GF Score
Get the complete analysis for FRA:PB8
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PB8 has been successfully added to your 
